Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis
Status:
Unknown status
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This is an randomized, double-blind, double-dummy trial, and the objective is to compare the
efficacy and safety of Mycophenolic acid (MA) and Azathioprine (AZA), immunosuppressive
drugs, in myasthenia gravis patients. This prospective study will enroll 40 myasthenia gravis
(MG) patients who are poor controlled under prior steroid therapy. All subjects should be
randomly assigned to MA group and AZA group that will receive routine pyridostigmine and
prednisolone in combination with MA or AZA.